| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:CTSL/CAPN1-IN-2
CAS:2410075-64-6
Package:10mg;50mg
|
|
| | 3-Piperidinebutanamide, β-[[(2S)-2-[(2-benzofuranylcarbonyl)amino]-3-cyclohexyl-1-oxopropyl]amino]-α,2-dioxo-N-(phenylmethyl)-, (βS,3S)- Basic information |
| | 3-Piperidinebutanamide, β-[[(2S)-2-[(2-benzofuranylcarbonyl)amino]-3-cyclohexyl-1-oxopropyl]amino]-α,2-dioxo-N-(phenylmethyl)-, (βS,3S)- Chemical Properties |
| density | 1.225±0.06 g/cm3(Predicted) | | pka | 11.94±0.46(Predicted) |
| | 3-Piperidinebutanamide, β-[[(2S)-2-[(2-benzofuranylcarbonyl)amino]-3-cyclohexyl-1-oxopropyl]amino]-α,2-dioxo-N-(phenylmethyl)-, (βS,3S)- Usage And Synthesis |
| Uses | CTSL/CAPN1-IN-2 (Compound 14b) is an orally active inhibitor of both CTSL and CAPN1, with IC50 values of 6.88 nM and 347.6 nM, respectively. CTSL/CAPN1-IN-2 possesses anti-inflammatory properties and favorable pharmacokinetic characteristics. CTSL/CAPN1-IN-2 exhibits broad-spectrum antiviral activity against coronaviruses by blocking viral entry[1]. | | References | [1] Xie X, et al. Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1. Signal Transduct Target Ther. 2024 Mar 6;9(1):54. DOI:10.1038/s41392-024-01758-8 |
| | 3-Piperidinebutanamide, β-[[(2S)-2-[(2-benzofuranylcarbonyl)amino]-3-cyclohexyl-1-oxopropyl]amino]-α,2-dioxo-N-(phenylmethyl)-, (βS,3S)- Preparation Products And Raw materials |
|